Ibrance
palbociclib
Breast Neoplasms
Date of authorisation:
Revision: 16
Last updated:
MedicineHumanAuthorised
EMEA-002146-PIP01-17-M04 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Oncology
PIP number: P/0117/2022
Route(s) of administration: Oral use
Pharmaceutical form(s):
Age-appropriate oral dosage form
Capsule (hard)
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-002146-PIP02-18 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Oncology
PIP number: P/0005/2019
Route(s) of administration: Oral use
Pharmaceutical form(s):
Capsule (hard)
Age-appropriate oral dosage form
Tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman